What is the greatest cause of cancer patient mortality?
Cell Response Ltd
Biotechnology Research
We're dedicated to defeating cancer drug resistance.
About us
Over 90% of cancer patient mortality is due to drug resistance and most clinical trials fail due to drug resistance. Our proprietary synthetic lethality screening platform, Resistome™, rapidly identifies drug-specific resistance mechanisms and evaluates drug combinations which overcome drug-specific resistance to extend life for patients, as well as identifying refined biomarker strategies to improve the stratification of patients for treatment.
- Website
-
www.cellresponsetx.com
External link for Cell Response Ltd
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held
- Specialties
- oncology drug resistance
Employees at Cell Response Ltd
Updates
-
Cell Response launches proprietary synthetic-lethality screening platform: Resistome™ - see our press release... https://lnkd.in/eNYpuZpr